Loading clinical trials...
Loading clinical trials...
This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like set...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HRA Pharma
NCT06162611 · Emergency Contraception
NCT03614494 · Emergency Contraception
NCT02078414 · Emergency Contraception, Contraception, and more
NCT03395756 · Emergency Contraception, Contraception
NCT04172584 · Emergency Contraception
HRA Pharma Investigational Site
Rancho Cucamonga, California
HRA Pharma Investigational Site
Boulder, Colorado
HRA Pharma Investigational Site
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions